Related references
Note: Only part of the references are listed.Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder
Bruce J. Schlomer et al.
JOURNAL OF UROLOGY (2010)
A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy
Jared Whitson et al.
BJU INTERNATIONAL (2009)
Reflex UroVysion Testing in Suspicious Urine Cytology Cases
Susana Ferra et al.
CANCER CYTOPATHOLOGY (2009)
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guerin therapy
Spasenija Savic et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
COST IMPLICATION OF USING UROVYSION IN SURVEILLANCE CARE FOR NON-INVASIVE BLADDER CANCER
G. John Chen et al.
JOURNAL OF UROLOGY (2009)
The value of the UroVysion® assay for surveillance of non-muscle-invasive bladder cancer
Sigurdur Gudjonsson et al.
EUROPEAN UROLOGY (2008)
Urinary markers in bladder cancer
Olaf P. J. Vrooman et al.
EUROPEAN UROLOGY (2008)
Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: Do risk factors define feasibility of bladder-sparing approach?
Stefan Denzinger et al.
EUROPEAN UROLOGY (2008)
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder
Marko Babjuk et al.
EUROPEAN UROLOGY (2008)
Molecular pathogenesis of bladder cancer
Margaret A. Knowles
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder
Yair Lotan et al.
JOURNAL OF UROLOGY (2008)
Assessing the value of reflex fluorescence in situ hybridization testing in the diagnosis of bladder cancer when routine urine cytological examination is equivocal
Benjamin R. Kipp et al.
JOURNAL OF UROLOGY (2008)
Editorial Comment on: The Value of the UroVysion® Assay for Surveillance of Non–Muscle-Invasive Bladder Cancer
Armin Pycha
EUROPEAN UROLOGY (2007)
Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology
Michal Daniely et al.
CANCER CYTOPATHOLOGY (2007)
Voided urinary cytology in bladder cancer: Is it time to review the indications?
Raghav Talwar et al.
UROLOGY (2007)
UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer
Paula M. J. Moonen et al.
EUROPEAN UROLOGY (2007)
Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology - A prospective of study with focus on the natural history of anticipatory positive findings
Brian J. Yoder et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Delay in the surgical treatment of bladder cancer and survival: Systematic review of the literature
Nader M. Fahmy et al.
EUROPEAN UROLOGY (2006)
Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer
Tobias Zellweger et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria
MF Sarosdy et al.
JOURNAL OF UROLOGY (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
DNA-based molecular cytology for bladder cancer surveillance
JS Jones
UROLOGY (2006)
Fluorescence in situ hybridization for detecting transitional cell carcinoma:: implications for clinical practice
J Laudadio et al.
BJU INTERNATIONAL (2005)
Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization
BR Kipp et al.
JOURNAL OF UROLOGY (2005)
Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology
M Skacel et al.
JOURNAL OF UROLOGY (2003)
Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology
J Placer et al.
EUROPEAN UROLOGY (2002)
Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer
MF Sarosdy et al.
JOURNAL OF UROLOGY (2002)
Noninvasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine
S Ishiwata et al.
UROLOGY (2001)
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma
KC Halling et al.
JOURNAL OF UROLOGY (2000)
The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine
IA Sokolova et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2000)
Share Paper
